New data presented at the Royal College of General Practitioners (RCGP) Annual Conference today1 reveals that in real world general practice, C-reactive protein point of care testing (CRP POCT) successfully helped to identify patients who did not require antibiotics, when presenting with symptoms of respiratory tract infections (RTIs)1. This is the first time that real life clinical data on the use of CRP POCT in general practice in England has been presented at a UK meeting.

The study included 99 patients, aged 5-75 years who visited their GP with a chesty cough. After undergoing a clinical scoring system, each patient's CRP levels were measured at the point of care using the Alere* AfinionTM CRP test1. Only 13% of these patients needed antibiotic treatment as the CRP POCT had concluded higher CRP levels. Within one month, 17% of the 99 patients returned to the surgery and only 5% were prescribed antibiotics1.

Almost 80% of antibiotics are prescribed in primary care and RTIs are the reason for 60% of these antibiotic prescriptions2. The vast majority of these infections are self-limiting or caused by viruses in which case antibiotics have little or no clinical benefit for patients. Previous studies have shown that CRP POCT can reduce antibiotic prescribing for RTIs in primary care by up to 41.5%3 and could save the NHS £56 million a year in prescription and dispensing costs alone4.

Dr Rob Cook, who was involved in the study and a GP from London says, "This study was conducted to see how feasible and useful CRP POCT is in real world general practice. We found that the test could be easily incorporated into routine care and provided very useful information for GPs and patients presenting with a cough. The vast majority of patients were reassured by a low CRP level and did not receive antibiotics."

He continued, "NICE has recommended point of care testing in primary care for lower respiratory tract infections and advises it is considered after clinical assessment as it can reduce use of antibiotics. But it is acknowledged that real life experience in the UK is limited and so was uncertain what the impact might be for work flow in the GP setting. Reducing antimicrobial resistance is becoming a national priority for all healthcare systems. By using CRP POCT GPs can play their part in this and further promote rational prescribing of antibiotics."

The study also provides insights on patients' expectations of receiving antibiotics. All participants had to complete a questionnaire in which they were asked whether they expected to receive antibiotics for their symptoms. Of the 26 patients expecting to receive antibiotics, only 7 (27%) patients received them1. Additionally, patients with lower CRP levels (who therefore would not have been suitable for antibiotics), were more likely to expect an antibiotic when asked1.

CRP POCT takes less than five minutes from a finger stick blood sample to provide a quantitative result and helps to facilitate an effective conversation between patients and GPs around the rational use of antibiotics1. It is already used in routine management in several European countries to aid diagnosis in suspected RTI and guide decision making regarding antibiotic prescribing. Despite this, the UK continues to lag behind with CRP POCT still less widely used in the UK than in other European countries, many of which have lower rates of antibiotic usage5.

About CRP POCT

C-reactive protein (CRP) is a biomarker in blood which indicates the presence of inflammation, and the amount of CRP in the body gives an indication of the severity of an infection. Low levels of CRP are indicative of viral or self-limiting bacterial infections, and high levels indicate serious infection.

CRP POCT helps GPs quickly determine whether a patient needs antibiotics for a respiratory tract infection, help doctors to target the use antibiotics, reducing both the number of antibiotics that are used and also the potential for misdiagnosis.

UK antibiotic prescribing

UK antibiotic prescribing rates are considerably higher than the rates of prescribing in other northern European countries2. Around 79% of UK antibiotic prescribing is in primary care6, yet rapid POC tests are rarely (if ever) used to make decisions about antibiotic prescribing in this setting. Nationally, 41.6 million antibacterial prescriptions were issued in 2013 -14 at a cost to the NHS of £192 million7. Despite considerable guidance that prescribing rates of antibiotics should be reduced, 9 out of 10 GPs feel pressured to prescribe antibiotics8, and 97% of patients who ask for antibiotics are prescribed them9.